These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 32708430)

  • 1. Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm.
    Fakhouri EW; Peterson SJ; Kothari J; Alex R; Shapiro JI; Abraham NG
    Antioxidants (Basel); 2020 Jul; 9(7):. PubMed ID: 32708430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pivotal Role of Adipocyte-Na K peptide in Reversing Systemic Inflammation in Obesity and COVID-19 in the Development of Heart Failure.
    Xie ZJ; Novograd J; Itzkowitz Y; Sher A; Buchen YD; Sodhi K; Abraham NG; Shapiro JI
    Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33202598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.
    Rossi M; Piagnerelli M; Van Meerhaeghe A; Zouaoui Boudjeltia K
    Med Hypotheses; 2020 Nov; 144():110242. PubMed ID: 33254548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
    Garvin MR; Alvarez C; Miller JI; Prates ET; Walker AM; Amos BK; Mast AE; Justice A; Aronow B; Jacobson D
    Elife; 2020 Jul; 9():. PubMed ID: 32633718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 infection and smoking: What is the association? A brief review.
    Gupta I; Sohail MU; Elzawawi KE; Amarah AH; Vranic S; Al-Asmakh M; Al Moustafa AE
    Comput Struct Biotechnol J; 2021; 19():1654-1660. PubMed ID: 33777332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.
    Mezoh G; Crowther NJ
    Adv Exp Med Biol; 2021; 1321():33-43. PubMed ID: 33656711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
    Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
    Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
    Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
    Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment.
    Zawilska JB; Lagodzinski A; Berezinska M
    J Physiol Pharmacol; 2021 Aug; 72(4):. PubMed ID: 34987123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
    Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
    Front Immunol; 2022; 13():888897. PubMed ID: 35663932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
    Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
    Front Immunol; 2021; 12():629193. PubMed ID: 33732251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure.
    Stasi A; Castellano G; Ranieri E; Infante B; Stallone G; Gesualdo L; Netti GS
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33334050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
    Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
    Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A global treatments for coronaviruses including COVID-19.
    Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M
    J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Journey into the Clinical Relevance of Heme Oxygenase 1 for Human Inflammatory Disease and Viral Clearance: Why Does It Matter on the COVID-19 Scene?
    Toro A; Ruiz MS; Lage-Vickers S; Sanchis P; Sabater A; Pascual G; Seniuk R; Cascardo F; Ledesma-Bazan S; Vilicich F; Vazquez E; Gueron G
    Antioxidants (Basel); 2022 Jan; 11(2):. PubMed ID: 35204159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of Evidence for a Role of ACE-2 Polymorphisms as a Bedside Clinical Prognostic Marker of COVID-19.
    Fiore JR; Di Stefano M; Oler A; Zhang Y; Gu J; Dalgard CL; Faleo G; Epling B; Notarangelo L; Lisco A; Santantonio TA
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.